The binuclear metalloenzyme purple acid phosphatase (PAP) [1], which may be involved in disorders such as osteoporosis [2][3][4], Gaucher disease [5], hairy cell leukemia [6], and AIDS [7] is widely distributed in mammalian tissues [8,9]. The expression level of PAP [also referred to as tartrate resistant acid phosphatase (TRAP) or type 5 acid phosphatase (AcP5; EC 3.1.3.2)] is elevated in these disorders, suggesting a relationship between the increased levels of the enzyme and the clinical picture. The presumed role of PAP makes it important to develop drugs that can inhibit PAP activity. In order to facilitate this process, the precise catalytic mechanism must be elucidated, including the function of each residue involved in catalysis.Although the available crystal structures of PAPs [10][11][12] provide structural information about the residues potentially involved in catalysis, to date only structures of inactive redox and protonation states of the enzymes have been reported. All structures show an active site composed of two metal ions bridged by a solvent-derived species and a bidentate aspartate residue. In addition, the iron(III) ion is coordinated by a tyrosinate [resulting in a ligand-to-metal charge transfer (LMCT) transition that is responsible for the Proteolysis of single polypeptide mammalian purple acid phosphatases (PAPs) results in the loss of an interaction between the loop residue Asp146 and the active site residues Asn91 and ⁄ or His92. While Asn91 is a ligand to the divalent metal of the mixed-valent di-iron center, the role of His92 in the catalytic mechanism is unknown. Site-directed mutagenesis of His92 was performed to examine the role of this residue in single polypeptide PAP. Conversion of His92 into Ala, which eliminates polar interactions of this residue with the active site, resulted in a 10-fold decrease in catalytic activity at the optimal pH. Conversely, conversion of this residue into Asn, which cannot function as either a proton donor or acceptor, but can provide hydrogen-bonding interactions, resulted in a three-fold increase in activity at the optimal pH. Both mutant enzymes had more acidic pH optima, with pK es,1 values consistent with the involvement of an iron(III) hydroxide unit or a hydroxide in the second coordination sphere in catalysis. These results, together with EPR data, support a role of His92 in positioning either the nucleophile or the substrate, rather than directly in acid or base catalysis. The existence of an extensive hydrogen-bonding network that could fine-tune the position of His92 is consistent with this proposal.Abbreviations kPP, protein phosphatase from phage k; KBPAP, kidney bean PAP; LMCT, ligand-to-metal charge transfer; MOI, multiplicity of infection; PAP, purple acid phosphatase; p-NPP, para-nitrophenylphosphate; PP, protein phosphatase; recHPAP, recombinant human purple acid phosphatase; recRPAP, recombinant rat PAP; TRAP, tartrate resistant acid phosphatase.